Novartis Internal Investigation: Up To 10,000 Side Effect Reports Delayed
This article was originally published in PharmAsia News
Executive Summary
There has been a delay in roughly 10,000 reports regarding side effects of Novartis products delivered by sales reps to the safety assessment department, according to a statement by the company on June 9.